COSCIENS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Goodwood Fund(7.2%),Goodwood Inc.(7.2%), etc.
COSCIENS Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
UPLOAD: Others
AEterna Zentaris | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CORRESP: CORRESP
UPLOAD: Others
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 424B3: Prospectus
AEterna Zentaris | 424B3: Prospectus
AEterna Zentaris | 424B3: Prospectus
AEterna Zentaris | 424B3: Prospectus
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | SC 13G: Statement of acquisition of beneficial ownership by individuals-Goodwood Fund(7.2%),Goodwood, Inc.(7.2%), etc.
AEterna Zentaris | EFFECT: Others
AEterna Zentaris | EFFECT: Others
No Data